UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High cumulative JC virus seroconversion rate during long-term use of natalizumab

European journal of neurology, 2016-06, Vol.23 (6), p.1079-1085

2016

Volltextzugriff (PDF)

John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients

European journal of neurology, 2017-09, Vol.24 (9), p.1196-1199

2017

Volltextzugriff (PDF)

High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rate

Multiple sclerosis and related disorders, 2019-06, Vol.31, p.32-37

2019

Volltextzugriff (PDF)

PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation

Case reports in neurological medicine, 2014-01, Vol.2014 (2014), p.1-4

2014

Volltextzugriff (PDF)

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

Multiple sclerosis, 2015-04, Vol.21 (4), p.481-484

2015

Volltextzugriff (PDF)

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

Neurology, 2011-02, Vol.76 (6), p.574-576

2011

Volltextzugriff (PDF)

Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS

Neurology, 2010-10, Vol.75 (14), p.1228-1233

2010

Volltextzugriff (PDF)

Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2023-06, Vol.94 (6), p.482-486

2023

Volltextzugriff (PDF)

The History of the International Society of Renal Nutrition and Metabolism, 1977–2006

Journal of renal nutrition, 2007-09, Vol.17 (5), p.289-295

Vennegoor, Marianne A., RD

2007

Volltextzugriff (PDF)

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

Neurology, 2011-09, Vol.77 (10), p.1020; author reply 1020-1020

2011

Volltextzugriff (PDF)

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007

Kidney international, 2008-12, Vol.74 (12), p.1516-1525

2008

Volltextzugriff (PDF)

Dietary Guidelines for the Management of Diabetic Patients with Chronic Renal Failure

Diabetic medicine, 1986-01, Vol.3 (1), p.75-79

1986

Volltextzugriff (PDF)

Renal replacement therapy. 4-1. Dietary management in renal dialysis and transplantation--2

Nursing times (1987), 1982-05, Vol.78 (20), p.847-851

Vennegoor, M A

1982

Volltextzugriff (PDF)

Renal replacement therapy. 3-2. Dietary management in renal dialysis and transplantation - 1

Nursing times (1987), 1982-05, Vol.78 (19), p.803-806

Vennegoor, M A

1982

Volltextzugriff (PDF)

Implementation of the Health Promoting School Approach in Europe: A Cross‐Sectional Study Among National Representatives

The Journal of school health, 2024-08, Vol.94 (10), p.975-984

2024

Volltextzugriff (PDF)

Dietary management of diabetics with chronic renal failure

Practical diabetes international, 1986-03, Vol.3 (2), p.71-73

1986

Volltextzugriff (PDF)

EBPG on Vascular Access

Nephrology, dialysis, transplantation, 2007-05, Vol.22 (suppl-2), p.ii88-ii117

2007

Volltextzugriff (PDF)

Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: the immune response to antibody therapeutics preferentially targets the antigen binding site

Journal of allergy and clinical immunology, 2017-03, Vol.139 (3), p.1035-1037.e6

2017

Volltextzugriff (PDF)

EBPG Guideline on Nutrition

Nephrology, dialysis, transplantation, 2007-05, Vol.22 (suppl-2), p.ii45-ii87

2007

Volltextzugriff (PDF)

MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance

Journal of neurology, neurosurgery and psychiatry, 2016-10, Vol.87 (10), p.1138-1145

2016

Volltextzugriff (PDF)

MRI pattern in asymptomatic natalizumab-associated PML

Journal of neurology, neurosurgery and psychiatry, 2015-07, Vol.86 (7), p.793-798

2015

Volltextzugriff (PDF)

Conditions for professional support of school health promotion implementation in the Netherlands

European journal of public health, 2023-10, Vol.33 (Supplement_2)

2023

Volltextzugriff (PDF)

Conditions for implementation of whole school health promotion in the Netherlands

European journal of public health, 2023-10, Vol.33 (Supplement_2)

2023

Volltextzugriff (PDF)

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

Multiple sclerosis, 2013-04, Vol.19 (5), p.593-600

2013

Volltextzugriff (PDF)

EBPG guideline on haemodynamic instability

Nephrology, dialysis, transplantation, 2007-05, Vol.22 (suppl-2), p.ii22-ii44

2007

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(62)
Science & Technology
(62)
Humans
(58)
Biological And Medical Sciences
(27)
Medical Sciences
(26)
Female
(25)
Clinical Neurology
(23)
Male
(23)
Neurosciences & Neurology
(23)
Adult
(22)
Multiple Sclerosis
(18)
Middle Aged
(16)
Natalizumab
(15)
Animals
(14)
Neurosciences
(13)
Oncology
(13)
Leukoencephalopathy, Progressive Multifocal - Chemically Induced
(12)
Multiple Sclerosis - Drug Therapy
(11)
Immunologic Factors - Adverse Effects
(9)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High cumulative JC virus seroconversion rate during long-term use of natalizumab

John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients

High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rate

PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS

Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis

The History of the International Society of Renal Nutrition and Metabolism, 1977–2006

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007

Dietary Guidelines for the Management of Diabetic Patients with Chronic Renal Failure

Renal replacement therapy. 4-1. Dietary management in renal dialysis and transplantation--2

Renal replacement therapy. 3-2. Dietary management in renal dialysis and transplantation - 1

Implementation of the Health Promoting School Approach in Europe: A Cross‐Sectional Study Among National Representatives

Dietary management of diabetics with chronic renal failure

EBPG on Vascular Access

Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: the immune response to antibody therapeutics preferentially targets the antigen binding site

EBPG Guideline on Nutrition

MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance

MRI pattern in asymptomatic natalizumab-associated PML

Conditions for professional support of school health promotion implementation in the Netherlands

Conditions for implementation of whole school health promotion in the Netherlands

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

EBPG guideline on haemodynamic instability

Suchergebnisse filtern